These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14305154)

  • 1. TREATMENT OF EXPERIMENTAL CARDIOGENIC SHOCK.
    BLOCH JH; PIERCE CH; MANAX WG; LILLEHEI RC
    Surgery; 1965 Jul; 58():197-214. PubMed ID: 14305154
    [No Abstract]   [Full Text] [Related]  

  • 2. HEMODYNAMIC EFFECTS OF RAPID DIGITALIZATION IN EXPERIMENTAL CARDIOGENIC SHOCK.
    CRONIN RF; ZSOTER T
    Am Heart J; 1965 Feb; 69():233-40. PubMed ID: 14256701
    [No Abstract]   [Full Text] [Related]  

  • 3. THE INOTROPIC EFFECT OF L-NORADRENALINE IN EXPERIMENTAL CARDIOGENIC SHOCK.
    CRONIN RF; TAN EH
    Can J Physiol Pharmacol; 1965 Jan; 43():55-68. PubMed ID: 14324232
    [No Abstract]   [Full Text] [Related]  

  • 4. THE EFFECT OF ENDOTOXIN AND VASOACTIVE AGENTS ON DIBENZYLINE-PRETREATED LUNGS.
    SUKHNANDAN R; THAL AP
    Surgery; 1965 Jul; 58():185-96. PubMed ID: 14305153
    [No Abstract]   [Full Text] [Related]  

  • 5. THE MANAGEMENT OF EXPERIMENTAL ENDOTOXIN SHOCK. THE CIRCULATORY EFFECTS OF LEVARTERENOL, HYDROCORTISONE, PHENOXYBENZAMINE HYDROCHLORIDE, AND BLOOD VOLUME EXPANSION.
    SMITH LL; MULLER W; HINSHAW DB
    Arch Surg; 1964 Oct; 89():630-6. PubMed ID: 14186793
    [No Abstract]   [Full Text] [Related]  

  • 6. Relation of cardiac work to survival in cardiogenic shock in dogs.
    Dietzman RH; Lyons GW; Bloch JH; Lillehei RC
    JAMA; 1967 Mar; 199(11):825-9. PubMed ID: 4289696
    [No Abstract]   [Full Text] [Related]  

  • 7. HEMODYNAMIC ACTION OF VASOPRESSOR AND VASODEPRESSOR AGENTS IN ENDOTOXIN SHOCK.
    MORRIS JA; SMITH RW; ASSALI NS
    Am J Obstet Gynecol; 1965 Feb; 91():491-503. PubMed ID: 14259138
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
    Misra SN; Kezdi P
    Am J Cardiol; 1973 Jun; 31(6):724-35. PubMed ID: 4145230
    [No Abstract]   [Full Text] [Related]  

  • 9. THE USE OF DRUGS IN THE TREATMENT OF IRREVERSIBLE VASOCONSTRICTOR SHOCK.
    FITTS CT; SAWYER RB
    J Trauma; 1965 Jan; 5():11-5. PubMed ID: 14255170
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in hemodynamics during counterpulsation in experimental cardiogenic shock].
    Chazov EI; Bogoslovskiĭ VA; Ruda MIa; Trubetskoĭ AV
    Kardiologiia; 1970 Jun; 10(6):13-8. PubMed ID: 5530942
    [No Abstract]   [Full Text] [Related]  

  • 11. Mesenteric circulation in cardiogenic shock with and without alpha-receptor blockade.
    Hirsch LJ; Glick G
    Am J Physiol; 1973 Aug; 225(2):356-9. PubMed ID: 4146612
    [No Abstract]   [Full Text] [Related]  

  • 12. Reevaluation of the treatment of shock secondary to cardiac infarction.
    Corday E; Vyden JK; Lang TW; Boszormenyi E; Carvalho M; Gold H; Goldman A; Rosselot E
    Dis Chest; 1969 Sep; 56(3):200-9. PubMed ID: 5821787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cardiovascular effects of hydroxytyramine (dopamine) and its importance for the therapy of cardiogenic shock in heart infarct. 2. Experimental studies on hypodynamic hearts of dogs].
    Urbaszek W; Günther K; Trenckmann H; Döring D
    Z Gesamte Inn Med; 1970 Apr; 25(7):290-3. PubMed ID: 4398843
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of experimental shock: comparison of the effects of norepinephrine, dibenzyline, dextran, whole blood, and balanced saline solutions.
    Rush BF
    Surgery; 1967 Jun; 61(6):938-44. PubMed ID: 6026142
    [No Abstract]   [Full Text] [Related]  

  • 15. [Acute coronary oclussion and cardiogenic shock. Experimental study with closed thorax].
    Malpartida F; Martínez-Caro D
    Arch Inst Cardiol Mex; 1975; 45(1):82-97. PubMed ID: 1130916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of dopamine on cardiogenic and endotoxin experimental shock.
    Marchetti G; Longo T; Merlo L; Noseda V
    Eur Surg Res; 1973; 5(3):175-85. PubMed ID: 4584042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of the blood plasma depressor prostaglandin content and the indicators of hemodynamics in dogs with experimental myocardial infarct and cardiogenic shock].
    Aleshin OI; Zykova VP; Beliakov KF; Beliaeva TE
    Kardiologiia; 1979 Jan; 19(1):80-7. PubMed ID: 439598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of the sympathetic nervous system during cardiogenic shock.
    Dietzman RH; Romero LH; Beckman CB; Shatney CH; Lillehei RC
    Surg Gynecol Obstet; 1973 Nov; 137(5):773-83. PubMed ID: 4746498
    [No Abstract]   [Full Text] [Related]  

  • 19. THE NATURE OF IRREVERSIBLE SHOCK: EXPERIMENTAL AND CLINICAL OBSERVATIONS.
    LILLEHEI RC; LONGERBEAM JK; BLOCH JH; MANAX WG
    Ann Surg; 1964 Oct; 160(4):682-710. PubMed ID: 14210369
    [No Abstract]   [Full Text] [Related]  

  • 20. EXTRACORPOREAL RECIPIENT SHUNT HOMOGRAFT KIDNEY PERFUSION. A MODEL FOR ORGAN RESUSCITATION AND FUNCTION EVALUATION.
    GILSDORF RB; CLARK SD; LEONARD AS
    Trans Am Soc Artif Intern Organs; 1965; 11():219-24. PubMed ID: 14329087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.